Company Comparison
Evelo Biosciences vs BioAnalytics Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Evelo Biosciences | BioAnalytics Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Cambridge |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $260M | $45M |
| Valuation | — | — |
What They Build
Evelo Biosciences
Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.
BioAnalytics Pro
Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.
Key Investors
Evelo Biosciences
BioAnalytics Pro
No investors listed.
Sector Overlap
Both Evelo Biosciences and BioAnalytics Pro operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.